Envision Pharma Group

We’re excited to announce our partnership with Nested Knowledge, Inc., integrating its AI-powered evidence synthesis technology into our #EnvisionOne platform. This collaboration streamlines evidence management by connecting Nested Knowledge’s advanced workflows – such as AI-assisted search, screening, and synthesis – with EnvisionOne’s capabilities.   The result? Faster, more efficient publication planning and real-time insights to support strategic decision-making for life sciences teams. As our CTO, Jim Streeter, shares: "What excites me most is our ability to bring truly world-class AI solutions together for our clients in a connected and integrated manner, so they have specialist systems working in unison to deliver speed and efficiency." Read the announcement here: https://lnkd.in/eXQB64bB #AI #Technology #Healthcare

The Envision team is thrilled to be attending #ISMPPEurope! This year’s theme, Core Values for an Integrated Age, aligns perfectly with our vision of leveraging combined intelligence to accelerate patient access to life-changing treatments. We’re excited to reconnect with friends old and new as we explore innovative solutions, so let’s discuss how we can collaborate and drive impactful change together. #EnvisionPharma #Technology #ISMPP #Europe

"The journey toward a fully realized AI-driven future in pharma may be complex, but the rewards for those who successfully navigate this path will be transformative." – Jim Streeter, President of Technology, Chief Technology Officer. As the pharmaceutical industry evolves, embracing AI is becoming essential for medical affairs professionals. In our latest guidebook, "AI adoption guidebook for medical affairs," Jim Streeter and Yahya Anvar, Head of OKRA.ai, provide insights on how AI can enhance data analytics, streamline content creation, and ultimately improve patient outcomes. Explore practical strategies to assess your organization's readiness for AI and pinpoint key areas where it can deliver immediate impact and value. Download the guidebook now! 👇 https://lnkd.in/eT68vwUN #AIinPharma #MedicalAffairs #HealthcareInnovation

As we approach the end of the year, we would like to take some time to thank you for your trust and partnership. Enjoy this special holiday video card we created to celebrate the season and share our warmest wishes with you. We wish you and your loved ones #HappyHolidays and a wonderful New Year! 🎄

The future of medical affairs: What’s next? The growing volume of data, rise of artificial intelligence (AI), increasingly busy healthcare professionals (HCPs), and the persistent challenge of siloed structures in pharma are reshaping how medical affairs teams work. These changes demand innovation, collaboration, and a stronger focus on patient impact. What will drive the most significant transformation over the next 5 years in medical affairs? Please share your thoughts in the survey below, let’s shape the future of medical affairs together!

The holiday season is here, and we’re thrilled to recognize Home-Start Glasgow North and North Lanarkshire who teamed up with Gary Dever, Anne Marie McGonigal, and our incredible #Glasgow office to make the season a bit brighter for families in their community.

Medical Brain by OKRA.ai, an Envision Pharma Group company, leverages AI to help medical teams create a fully automated insights generation process that enables them to reach both local and global insights – all in a single platform. What makes the Medical Brain a game-changer? It empowers medical teams to uncover trends, monitor sentiment, pinpoint evidence gaps, and tackle unmet needs effortlessly – reducing time to insights by 80%. Explore our latest case study to see the Medical Brain in action 👉 https://lnkd.in/eci9R6an

Envision Medical Communications Scientific Director Sarah McSorley explores the increasing collaboration between #MedicalAffairs and #PatientEngagement in this insightful article for the Medical Affairs Professional Society (MAPS). Sharing their insights with Sarah are Avishek Pal, Dakota Fisher-Vance, and Jackie Zimmerman, who discuss the differing approaches between established and emerging pharmaceutical companies. They also highlight how various functions can work together to support meaningful patient involvement throughout the medicine development process. As Jackie notes, “There is an opportunity for biopharmaceutical companies to speak directly to their core client base and to learn what their communities want and need.” Read the full article here 👇 https://lnkd.in/efkQCGCM #LifeSciences

The fusion of #technology, data, AI/ML, and tech-enabled services is revolutionizing today’s #medaffairs capabilities and workflows. Join us at Accelerate EU 2025 in London – immediately following the #ISMPP EU conference – and connect with industry leaders, share insights, and build valuable relationships. Register today! > https://lnkd.in/eZSzDujK

We’re proud to share that Envision Pharma Group’s OKRA.ai is named as a Sample Vendor in the Gartner® Hype Cycle™ for Life Science Commercial Operations, 2024 report. A key focus of the report is scaling the use of data and analytics to accelerate decision-making processes and improve strategic outcomes – a guiding principle we share at Envision. Our proprietary AI technology, Medical Brain, transforms data into actionable medical insights highlighting significant trends, sentiments, evidence gaps, and unmet needs – all within a single, unified solution, proven to reduce time to action by up to 80%. Ready to learn more? Access the full reprint from Gartner® including commentary, analysis, and what’s new here: https://lnkd.in/eKEYkXh4. #MedicalAffairs #MedicalData #HealthcareInnovation